Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease

Neurology

Volumn 46, Issue 6, 1996, Pages 1548-1551

  Carpentier, A F ^a   Bonnet, A M ^a   Vidailhet, M ^a   Agid, Y ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; BROMOCRIPTINE; DECARBOXYLASE INHIBITOR; LEVODOPA; LISURIDE MALEATE; PERGOLIDE; PROPRANOLOL;

ADULT; ARTICLE; CHOREA; CLINICAL ARTICLE; DOSE RESPONSE; DYSKINESIA; FEMALE; HEMIBALLISM; HUMAN; MALE; MOTOR DYSFUNCTION; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029884740     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.6.1548     Document Type: Article

References (13)

1. Marsden CD, Parkes JD, Quinn N. Fluctuations of disability in Parkinson's disease: clinical aspects. In: Marsden CD, Fahn S, eds. Movement disorders. London: Butterworth, 1982:96-122.
2. Muenter MD, Sharpless NS, Tyce GM, Darley FL. Patterns of dystonia ("I-D-I" and "D-I-D") in response to L-dopa therapy for Parkinson's disease. Mayo Clin Proc 1977;52;163-174.
3. Lhermitte F, Agid Y, Signoret JL, Studler JM. Les dyskinésies de "début et fin de dose" provoquées par la L-dopa. Rev Neurol (Paris) 1977;133:297-308.
4. Bylund DB, Snyder SH. Beta-adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol 1976;12:568-580.
5. Reisine TD, Chesselet MF, Lubetzki C, Chéramy A, Glowinsky J. A role for striatal beta-adrenergic receptors in the regulation of dopamine release. Brain Res 1982;241:123-130.
6. Esteguy M, Bonnet AM, Kefalos J, Lhermitte F, Agid Y. Le test à la L-dopa dans la maladie de Parkinson. Rev Neurol (Paris) 1985;141:413-415.
7. Marconi R, Lefebvre-Caparros D, Bonnet AM, Vidailhet M, Dubois B, Agid Y. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. Mov Disord 1994;9:2-12.
8. Gomez-Mancilla B, Bédard PJ. Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys. Clin Neuropharmacol 1993;16:418-427.
9. Koller WC, Herbster G. Adjuvant therapy of parkinsonian tremor. Arch Neurol 1987;44:921-923.
10. 2-adrenergic agonist as adjunct therapy to levodopa in Parkinson's disease. Neurology 1994;44:1511-1513.
11. Agid Y, Bonnet AM, Ruberg M, Javoy-Agid F. Pathophysiology of L-dopa-induced abnormal involuntary movements. Psychopharmacology (Germany, West) 1985;2(suppl):145-159.
12. Svensson TH. Peripheral, autonomie regulation of locus coeruleus noradrenergic neurons in brain: putative implications for psychiatry and psychopharmacology. Psychopharmacology 1987;92:1-7.
13. Lindvall O, Björklund A. The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol Scand Suppl 1974;412:1-48.